LTUS — Lotus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $12.69m
- $17.95m
- $72.70m
Annual cashflow statement for Lotus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | C2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.14 | 11.2 | 12.8 | 16.4 | 14.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.73 | -2.6 | 1.51 | 3.96 | 8.33 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.62 | -10 | 22.5 | 8.98 | 1.77 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 4.84 | -0.851 | 37.4 | 31.4 | 26.8 |
| Capital Expenditures | -0.001 | -0.382 | -1.45 | -28.7 | -29.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.24 | 0 | -40.5 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.24 | -0.382 | -41.9 | -28.7 | -29.4 |
| Financing Cash Flow Items | -0.737 | 0.012 | -1.5 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.19 | 3.47 | 0.981 | 0 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.93 | 2.47 | -3.28 | 2.67 | -2.61 |